title: The pricing of statins and implications for Pharmaceutical Benefits Scheme expenditure.
authors.forename: Philip M
authors.initials: PM
authors.lastname: Clarke
mesh_terms: D016527:Drug Costs; D016568:Drugs, Generic / Q000191:economics*; D005569:Formularies as Topic; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics*; D007356:Insurance, Pharmaceutical Services; D009313:National Health Programs; D010330:Patents as Topic
chemical_list: D016568:Drugs, Generic; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors